Composition :

Each vial contains :

Ceftizoxime sodium  IP equivalent to ceftizoxime     3000 mg

Indications:

For the treatment of clinical & subclinical mastitis.

Dosage & administration :

5 mg./kg. body weight and repeat after 96 hours in case of severe clinical mastitis by intravenous only

Safe in pregnancy

Presentation:

3 gm. vial with 20 ml., WFI, 20 ml. syringe & needle.

To know more about the product, click here.